首页> 外文期刊>Pakistan journal of medical sciences. >Reliability and validity test of VES-13 and analysis of influencing?factors for the vulnerable condition of patients with advanced castration-resistant prostate cancer
【24h】

Reliability and validity test of VES-13 and analysis of influencing?factors for the vulnerable condition of patients with advanced castration-resistant prostate cancer

机译:VES-13的可靠性和有效性测试及影响的分析 - 抗阉割前列腺癌患者脆弱病症的因素

获取原文
           

摘要

Objectives: To study the relationship between the reliability and validity of VES-13 and the influencing factors of the vulnerable condition of patients with advanced castration-resistant prostate cancer, so as to provide a reference for the health management and nursing of elderly inpatients. Methods: By means of convenience sampling, 150 vulnerable patients with advanced castration-resistant prostate cancer who were admitted to the Department of Oncology of the Affiliated Hospital of Hebei University from April 2019 to March 2020 were selected. General data questionnaire, simple mental state checklist, anxiety self-assessment scale, and the vulnerable elders 13 survey (VES-13) were used in this study. The reliability and validity were tested by SPSS 20.0. Results: For this group of patients, VES-13 Cronbach’s α was 0.832, living function was 0.778, body function was 0.846, and the correlation coefficient between items was between 0.401 and 0.823 (P0.01); the retest reliability was 0.831 (P0.05), and the correlation coefficient was0.504 (P0.05). The average time to fill in each scale was 4.53±1.32 Minutes, and general indicators such as economic status and education level were significantly correlated with vulnerability. The clinical indicators of prostate-specific antigen levels, multiple bone metastases, and bone pain were significantly correlated with vulnerability. Conclusion: VES-13 scale had high level of reliability and operability, and was straight forward to understand and use; it can be used as an effective tool for the assessment of vulnerability in patients with advanced prostate cancer. The vulnerability of patients with castration-resistant prostate cancer showed significant correlation with economic status, education level, prostate-specific antigen level, multiple bone metastases, bone pain and other indicators. Nursing staff should pay close attention to the relevant factors of inpatients and give targeted advance intervention measures to facilitate rapid recovery of elderly inpatients. doi: https://doi.org/10.12669/pjms.37.1.3095 How to cite this:Feng J, Sun Q, Li J, Li TT. Reliability and validity test of VES-13 and analysis of influencing factors for the vulnerable condition of patients with advanced castration-resistant prostate cancer. Pak J Med Sci. 2021;37(1):137-141.??doi: https://doi.org/10.12669/pjms.37.1.3095 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
机译:目的:研究VES-13的可靠性和有效性与抗阉割前列腺癌患者脆弱病情的影响,为老年住院患者的健康管理和护理提供参考。方法:通过便利取样,从2019年4月到2020年4月入学了150名抗阉割前列腺癌的前期阉割前列腺癌。一般数据问卷,简单的精神状态清单,焦虑自我评估规模和弱势群体13调查(VES-13)被用于本研究。可靠性和有效性由SPSS 20.0测试。结果:对于该组患者,VES-13 Cronbach的α为0.832,活性功能为0.778,体函数为0.846,物品之间的相关系数在0.401和0.823之间(P <0.01);重保持可靠性为0.831(P <0.05),相关系数为0.504(P <0.05)。填写每种比例的平均时间为4.53±1.32分钟,以及经济状况和教育水平的一般指标与脆弱性有显着相关。前列腺特异性抗原水平,多重骨转移和骨疼痛的临床指标与脆弱性显着相关。结论:VES-13规模具有高水平的可靠性和可操作性,并直接了解和使用;它可以作为评估晚期前列腺癌患者脆弱性的有效工具。抗阉割前列腺癌患者的脆弱性与经济地位,教育水平,特异性抗原水平,多重骨转移,骨疼痛等指标显着相关。护理人员应密切关注住院患者的相关因素,并提供有针对性的提前干预措施,以促进老年住院患者的快速恢复。 DOI:https://doi.org/10.12669/pjms.37.1.3095如何引用这个:冯j,sunq,li j,li tt。 VES-13的可靠性和有效性试验及其对抗阉割前列腺癌患者脆弱病情的影响分析。 Pak J Med Sci。 2021; 37(1):137-141。?? DOI:https://doi.org/10.12669/pjms.37.1.3095这是一个在Creative Commons归因许可证条款下分发的开放式访问文章(http:/ /creativeCommons.org/licenses/by/3.0),其允许在任何媒体中不受限制的使用,分发和再现,只要原始的工作被正确引用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号